A liquid biopsy involving a half-dozen cell-free and exosome-based circulating biomarkers showed high specificity and ...

As new technology capable of detecting dozens of early-stage cancer types with a single blood test hits the market, support ...

Blood is a rich source for biomarker development, and CTCs are increasingly proving themselves to be valuable in cancer ...

Special Report: Rhythm Biosciences surged more than 30% on Friday after confirming the commercial launch of its ColoSTAT ...

Colon cancer is no longer a disease that only impacts older adults. It is rising sharply in younger adults with one in five ...

Recently, a 31-year-old man got diagnosed with Colon Cancer. In an IG post, he listed down his symptoms, and why one must ...

"Shield" is the first FDA-approved blood test to screen for colorectal cancer. Gretchen Carlson Spills Why Trump's 'Piggy' Attack Strikes Her 'At The Core' ...

Freenome is taking itself public via a special purpose acquisition company, also known as a SPAC deal, to help raise funds in ...

A novel blood test analyzing fragments of cell-free DNA showed robust diagnostic performance for colorectal cancer across clinical subgroups, offering a promising noninvasive screening method.

Though none of the blood tests have been approved by federal regulators — and they cost hundreds of dollars — people are ...

Colon cancer is hitting long before the usual screening age. If you could ID who's at risk, you could screen early and save ...

“The research that’s needed most is the risk stratification research—who do we screen,” says Dr. Gabre. By getting to the ...